Skip to main content

2026 Global Regulatory Strategies Conference Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Title

Browse by Title

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#

O
Opening Night Networking Reception
Favorite
Opening Plenary: From Data to Decisions: The Expanding Role of Real‑World Evidence in Regulatory Submissions
Favorite

Marie Bradley – The U.S Food and Drug Administration ### 2944357###Panelist###Senior Advisor, Real-World Evidence, Office of Medical Policy###The U.S Food and Drug Administration###
Panelist: Marie Bradley – The U.S Food and Drug Administration
### @@@ Seema S. Betigeri, PhD – Merck & Co., Inc ### 828929###Panelist###Executive Director, Global Regulatory Affairs###Merck & Co., Inc###
Panelist: Seema S. Betigeri, PhD – Merck & Co., Inc
### @@@ Michelle Yu Kite, MS (she/her/hers) – Pfizer ### 2864100###Panelist###Director of Global Strategy, Oncology###Pfizer###
Panelist: Michelle Yu Kite, MS (she/her/hers) – Pfizer
### she/her/hers @@@ Lockwood G. Taylor, PhD, MPH – Flatiron Health ### 2908615###Panelist###Head of Regulatory Strategy###Flatiron Health###
Panelist: Lockwood G. Taylor, PhD, MPH – Flatiron Health
### @@@ Dona O'Neil, MPH, CCRP – BD ### 2939401###Panelist###Associate Director, Medical & Scientific Affairs###BD###
Panelist: Dona O'Neil, MPH, CCRP – BD
### @@@ Erin K. Grath, BS, MS – Agilent Technologies ### 1698213###Moderator###Associate Vice President ###Agilent Technologies ###
Moderator: Erin K. Grath, BS, MS – Agilent Technologies
###